CD4 and autoimmune lymphoproliferative syndrome: It is unclear whether low CD4 cell counts in the context of ALPS-FAS may increase the risk for opportunistic infection but specific clinical monitoring or targeted prophylactic intervention or immunization strategies may be considered in these patients, especially when immunomodulant intervention for treatment of ALPS-FAS is being adopted.